O. Khmelnitskiy

Nafamostat in hospitalized patients with moderate to severe COVID-19 pneumonia: a randomised Phase II clinical trial

A. Gritsan, Sei-Hyun Kim, S. Zhuravel, 2021, EClinicalMedicine.

Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial

H. Jessen, M. Pangalos, R. Fischer, 2022, The Lancet Respiratory Medicine.

Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Pneumonia

Andrés F. Agudelo, M. Levitt, N. Assy, 2022, medRxiv.